Atlas Trials

Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer

Clinical trial NCT02867956 · COMPLETED

Trial details

NCT number
NCT02867956
Sponsor
Sun Yat-sen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2016-08-10
Primary completion
2017-12-31
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.